Fast Five Quiz: Systemic Treatments for Plaque Psoriasis

Chris G. Adigun, MD; William James, MD


December 21, 2021

Prior to the initiation of systemic treatment for plaque psoriasis, patients should be assessed for risk of exposure to hepatitis, HIV, and other recurrent or chronic infections, as this may affect treatment choice. Testing for tuberculosis should also be performed, as should serum chemistry evaluations including electrolyte, renal, and hepatic panels and complete blood counts.

Presently, algorithms for choosing the most appropriate therapy among the newer systemic options for patients with psoriasis are lacking; however, general factors to consider can be found in recent guidelines from organizations such as the British Association of Dermatologists and the American Academy of Dermatology/National Psoriasis Foundation.

Learn more about systemic therapy for the treatment of plaque psoriasis.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.